Schematic representation of nanovaccine approaches for NSCLC management. (a) siRNA-based gene silencing within tumor cells. (b) TME remodeling via immune activation approach to enhance tumor destruction.

This review summarizes advances in #cancer #nanovaccines, highlighting #nanocarriers, and innovations such as #immunotherapeutic nanovaccines, STING agonist vaccines, and #nanogels, emphasizing their potential to reduce cancer recurrence.
Nanotechnology Reviews: doi.org/10.1515/ntre...